Connect with us

News

Israeli cannabis company gets backing from country’s healthcare giants

The move suggests that the medical establishment has finally put its faith in cannabis

Published

on

Tikun Olam-Cannbit has entered a five-year agreement with the Sourasky Medical Center in Tel Aviv

An Israeli medical cannabis company has teamed up with some of the country’s largest healthcare providers to make treatment accessible to more patients. 

Medical cannabis company, Tikun Olam-Cannbit recently announced it has entered into a partnership agreement with Israel’s second-largest healthcare provider, Maccabi Healthcare Services.

As part of the deal, Tikun Olam-Cannbit will offer Maccabi members who hold a medical cannabis license, discounts on its products and services, including the dispensing and distribution of products to the patient’s home, training on how to use a vape, consulting and webinars on the latest research.

It follows an arrangement made by the company with Meuhedet Health Services, that in addition to providing delivery, consulting and patient training services, will see the training of Meuhedet physicians and medical staff.

Tikun Olam-Cannbit has already entered a five-year agreement with one of Israel’s largest hospitals, Tel Aviv Sourasky Medical Center, to collaborate on the establishment of a Medical Cannabis Research Center on the campus in Tel Aviv, in conjunction with the hospital’s Medical Research Infrastructure and Health Services Fund.

The firm will conduct six clinical studies, three of which will be conducted within the next five years, and the rest within the next decade.

The study fund will examine possibility of developing analytical tools to identify blood endocannabinoid levels, receive access to analyse active ingredients and will also see the firm provide preclinical studies, publish joint academic publications and collaborate on projects using the hospital’s biobank.

Tikun Olam-Cannbit will provide its cannabis strains for studies that will be conducted at the research centre free of charge and will provide strains at a discount for clinical and preclinical studies for the other studies that will be conducted at the research centre. 

Avinoam Sapir, CEO of Tikun Olam-Cannbit said the recent developments were evidence that the Israeli medical establishment has put its faith in the efficacy of medical cannabis. 

“The agreement signed with Maccabi Healthcare Services comes on the heels of the agreement that was recently signed with Meuhedet Health Services and the agreement to establish the research institute with Tel Aviv Sourasky Medical Center,” he commented. 

“They all demonstrate the faith of the medical establishments in the therapeutic efficacy of medical cannabis based on clinical research. I welcome this important partnership and the selection of Tikun Olam-Cannbit for the second time by a leading medical institution.”

Sapir added: “The fact that another HMO has decided to include cannabis as part of the treatment services it offers and chooses to do so with Tikun Olam-Cannbit at this point testifies to the professional faith in our clinical knowledge and abilities to provide support throughout the medical cannabis value chain, based on proven clinical research and recognition of Tikun Olam-Cannbit as a pharmaceutical company.”

Sarah Sinclair is a respected cannabis journalist writing on subjects related to science, medicine, research, health and wellness. She is managing editor of Cannabis Health, the UK’s leading title covering medical cannabis and CBD, and sister titles, Cannabis Wealth and Psychedelic Health. Sarah has an NCTJ journalism qualification and an MA in Journalism from the University of Sunderland. Sarah has over six years experience working on newspapers, magazines and digital-first titles, the last two of which have been in the cannabis sector. She has also completed training through the Medical Cannabis Clinicians Society securing a certificate in Medical Cannabis Explained. She is a member of PLEA’s (Patient-Led Engagement for Access) advisory board, has hosted several webinars on cannabis and women's health and has moderated at industry events such as Cannabis Europa. Sarah Sinclair is the editor of Cannabis Health. Got a story? Email sarah@handwmedia.co.uk / Follow us on Twitter: @CannabisHNews / Instagram: @cannabishealthmag

Trending

Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2023 PP Intelligence Ltd.